Centerra Gold Inc. is not a strong buy at the moment for a beginner investor with a long-term strategy. Despite positive revenue growth and a diversified asset portfolio, the company's recent financial performance shows significant declines in net income and EPS. Technical indicators are mixed, with bearish MACD and RSI near neutral. Options data suggests low bearish sentiment, but no strong signals for immediate entry. Analyst ratings are mixed, with some positive price target revisions but also an underperform rating from BofA. The stock's recent price drop and lack of significant trading signals make it prudent to hold off on buying for now.
The MACD is bearish with a negatively expanding histogram (-0.126). RSI is at 35.702, indicating neutral momentum. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is nearing its support level at 18.3. The stock has a 70% chance to decline -3.28% in the next day and -0.04% in the next week, with a potential 5.57% gain in the next month.

Revenue increased by 32.80% YoY in Q4 2025, and the company has a diversified asset portfolio, including gold, copper, and molybdenum projects. Recent technical report filings for the Kemess Project may attract investor interest.
The MACD is bearish, and the stock price has declined significantly (-4.80% in the regular market). Analyst ratings are mixed, with one underperform rating and a price target below the current price.
In Q4 2025, revenue increased to $401.56M (+32.80% YoY), but net income dropped to $192.77M (-467.20% YoY), and EPS fell to 0.97 (-488.00% YoY). Gross margin improved to 40.69 (+54.42% YoY).
Analyst ratings are mixed. CIBC and Scotiabank have raised price targets and maintain Outperform ratings, citing increased gold price forecasts and geopolitical uncertainty. However, BofA maintains an Underperform rating with a price target of $14.50, below the current price.